Top

Familial Cancer

Published in:

01-03-2005

Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1

Review

Authors: Giuseppe Opocher, Pierantonio Conton, Francesca Schiavi, Beatrice Macino, Franco Mantero

Published in: Familial Cancer | Issue 1/2005

Title: Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1
Review
Authors: Giuseppe Opocher
Pierantonio Conton
Francesca Schiavi
Beatrice Macino
Franco Mantero
Publication date: 01-03-2005
Publisher: Kluwer Academic Publishers
Published in: Familial Cancer / Issue 1/2005
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-004-6128-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2005

Molecular pathogenesis of MEN2-associated tumors

SDHC mutations in hereditary paraganglioma/pheochromocytoma

Instructions for Authors

Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications

Imaging of pheochromocytoma and paraganglioma

Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx

Keynote webinar | Spotlight on antibody–drug conjugates in cancer